2023
DOI: 10.1016/j.ekir.2022.10.030
|View full text |Cite
|
Sign up to set email alerts
|

A Systematic Review and Meta-Analysis of the Rate and Risk Factors for Post-transplant Disease Recurrence in Children With Steroid Resistant Nephrotic Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 29 publications
(68 reference statements)
0
1
0
Order By: Relevance
“…The entire process is shown in Figure 1. After retrieving eligible studies, three reviewers (AAM, GVR, and AC) independently critically appraised the studies' methodology and categorized the risk of bias for each study according to the Joanna Briggs Institute (JBI) critical appraisal tools, as follows: ≤49% ("high"), 50-69% ("moderate"), and >70% ("low") [33][34][35][36]. The studies' risk of bias assessment results and the Joanna Briggs Institute (JBI) critical appraisal tools' checklists are provided in Appendices (Tables 5-8).…”
Section: Studies Selection and Data Extractionmentioning
confidence: 99%
“…The entire process is shown in Figure 1. After retrieving eligible studies, three reviewers (AAM, GVR, and AC) independently critically appraised the studies' methodology and categorized the risk of bias for each study according to the Joanna Briggs Institute (JBI) critical appraisal tools, as follows: ≤49% ("high"), 50-69% ("moderate"), and >70% ("low") [33][34][35][36]. The studies' risk of bias assessment results and the Joanna Briggs Institute (JBI) critical appraisal tools' checklists are provided in Appendices (Tables 5-8).…”
Section: Studies Selection and Data Extractionmentioning
confidence: 99%
“…In addition, patients with disease‐causing variants in some of the genes encoding enzymes of the coenzyme Q10 (CoQ10) pathway (e.g., COQ2 (OMIM 607426) and COQ6 (OMIM 614650)) can be treated using supplementation with CoQ10 (Preston et al, 2019 ). Furthermore, identification of disease‐causing mutations can facilitate the process of kidney donor selection and the prediction of post‐transplant recurrence of NS (Morello et al, 2023 ).…”
Section: Introductionmentioning
confidence: 99%